LOX and breast carcinoma: Figure 2 presents retrospective mRNA expression based on tissue microarray (TMA) analysis of LOX and LOXL1–LOXL4 in breast cancer tissue biopsy samples from 176 patients with breast cancer versus 10 healthy control human breast tissue samples.